ELIZABETH LEFAVE: Open Payments
NPI 1184755779 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,458 in 55 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,449 · 2025 $1,458
Food & beverage: $1,424Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $294 |
| Regeneron Healthcare Solutions, Inc. | 9 | $267 |
| AstraZeneca Pharmaceuticals LP | 8 | $246 |
| GENZYME CORPORATION | 5 | $134 |
| Amgen Inc. | 4 | $76 |
| Ionis Pharmaceuticals, Inc. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $55 |
| Greer Laboratories, Inc. | 2 | $52 |
| CSL Behring | 2 | $51 |
Products named: DUPIXENT, NUCALA, AIRSUPRA, TEZSPIRE, DAWNZERA, TRELEGY ELLIPTA, XOLAIR, TAKHZYRO.
Industry payments across FL — which companies pay providers there.
